Nichi-Iko Pharmaceutical Co., Ltd.
Nichi-Iko Pharmaceutical Co., Ltd. (4541.T) Stock Overview
Explore Nichi-Iko Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.5B
P/E Ratio
0.27
EPS (TTM)
$-159446450000.00
ROE
0.13%
4541.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nichi-Iko Pharmaceutical Co., Ltd. (4541.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 57.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $43.70.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.27 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.